They provided evidence that this hypoxia-activated, Akt2-dependent pathway is present in ovarian cancer through examining a panel of ovarian cancer cell lines in vitro as well as real-time PCR analysis of 31 human ovarian cancer samples. This evidence concerns the gene AKT2 and ovarian cancer.